Anemia Drug Works Regardless of Prior ESA Treatment
A study of anemic patients on peritoneal dialysis found that roxadustat maintained target hemoglobin levels even in those who received previous treatment with an erythropoiesis stimulating agent.
A study of anemic patients on peritoneal dialysis found that roxadustat maintained target hemoglobin levels even in those who received previous treatment with an erythropoiesis stimulating agent.
A recent study of patients with chronic kidney disease showed that each 1-km increase in the elevation where they live was associated with 33% decreased odds of anemia.
Transfusing red blood cells into cardiac surgery patients only when their hemoglobin levels fall to below 7.5 g/dL does not increase acute kidney injury risk.